Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32484
CAS Number:
136572-09-3
Chlorhydrate d'irinotécan trihydraté
Grade:
Meets USP specification
Purity:
98 - 102 % (dosage sur une base anhydre)
Synonym(s):
CPT-11 trihydraté
Documents
$65.00 /250 mg
Taille
Request Bulk Quote
Product Information

Conserver à l'abri des agents oxydants.

Synonyms
CPT-11 trihydraté
CAS Number
136572-09-3
Purity
98 - 102 % (dosage sur une base anhydre)
Grade
Meets USP specification
Molecular Formula
C33H38N4O6 · HCl · 3H2O
Molecular Weight
677.19
MDL Number
MFCD01765731
PubChem ID
22727521
Appearance
Poudre cristalline jaunâtre ou presque jaune
Conditions
Conserver entre 2 et 8 °C
General Information
Synonyms
CPT-11 trihydraté
CAS Number
136572-09-3
Purity
98 - 102 % (dosage sur une base anhydre)
Grade
Meets USP specification
Molecular Formula
C33H38N4O6 · HCl · 3H2O
Molecular Weight
677.19
MDL Number
MFCD01765731
PubChem ID
22727521
Appearance
Poudre cristalline jaunâtre ou presque jaune
Conditions
Conserver entre 2 et 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

Irinotecan hydrochloride trihydrate is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used in chemotherapy for treating colorectal cancer, providing effective tumor reduction and improved patient outcomes.
  • Pharmaceutical Development: Researchers leverage its properties to develop new formulations and delivery methods, enhancing the efficacy and reducing side effects of cancer therapies.
  • Clinical Trials: It plays a crucial role in clinical studies aimed at evaluating new cancer treatment regimens, helping to establish safety and effectiveness in diverse patient populations.
  • Combination Therapies: Irinotecan is often studied in combination with other anticancer agents, allowing for synergistic effects that can lead to better treatment responses.
  • Biomarker Research: Its use in research helps identify biomarkers for patient stratification, enabling personalized medicine approaches that tailor treatments to individual patient profiles.